Does body mass index affect stem cell yield in healthy donors?
Seda Yilmaz1, Nazik Okumus2, Mert Seyhan2
1University of Health Sciences, Konya Medical Faculty, Department of Hematology and Bone Marrow Transplantation Unit, Konya, Türkiye.
Summary
Higher body mass index (BMI) in healthy donors correlates with increased CD34+ stem cell yield during apheresis. This finding is crucial for optimizing hematopoietic stem cell transplantation procedures.
Area of Science:
- Hematology
- Transplant Immunology
- Biostatistics
Background:
- Hematopoietic stem cell transplantation (HSCT) is vital for treating hematologic diseases.
- Donor factors influencing hematopoietic progenitor cell yield require further investigation.
- Existing research on donor Body Mass Index (BMI) and its impact on stem cell mobilization is limited and conflicting.
Purpose of the Study:
- To investigate the relationship between donor BMI and hematopoietic progenitor cell yield.
- To analyze how BMI affects the efficacy of stem cell mobilization in healthy donors.
Main Methods:
- Retrospective analysis of 665 healthy donors, categorized by BMI (<25 kg/m² and ≥25 kg/m²).
- Evaluation of demographic data, smoking habits, blood groups, mobilization agents, apheresis parameters, and biochemical markers.
- Statistical comparison of stem cell yields (CD34+ cells) between BMI groups.
Main Results:
- Donors with BMI ≥25 kg/m² exhibited a statistically significant higher median CD34+ stem cell count (7.1 × 10⁶/kg on day 1 and 7.58 × 10⁶/kg total).
- Fewer apheresis days were required for donors in the higher BMI group.
- No significant differences were observed in smoking habits, blood groups, mobilization agents, processed blood volume, or most biochemical parameters (except LDH).
Conclusions:
- Donor BMI is a significant factor correlating with CD34+ stem cell yield in healthy individuals.
- Higher BMI in donors may be associated with enhanced stem cell mobilization efficiency.
- These findings can inform donor selection and apheresis protocols to optimize stem cell collection for HSCT.
Related Concept Videos
Source And Potency Of Stem Cells
5.2K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
5.2K
Bone Marrow Sampling and Transplants
504
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
504
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K


